GlassScriptPhysician profile
Brittnee L Angle
NPI 1174042055
$2,627.57
in general payments reported to CMS, 2019-2025
26 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $588 · 2023: $636 · 2024: $699 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,837.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $636.23 | 2022-2025 | |
| Abbott Laboratories | $374.55 | 2021-2025 | Cardiomems, Jot Dx, Aveir |
| Amgen INC. | $310.59 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $212.75 | 2021-2025 | |
| Novo Nordisk INC | $138.90 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Boston Scientific Corporation | $96.55 | 2024-2025 | Enroute Transcarotid Neuroprotection System, Bodyguardian |
| Lexicon Pharmaceuticals, INC. | $86.73 | 2024 | |
| Abiomed | $78.34 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.98 | 2021-2023 | Lifevest |
| Irhythm Technologies, INC. | $67.62 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Merck Sharp & Dohme LLC | $65.53 | 2023-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $60.25 | 2023-2024 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $60.05 | 2022-2024 | Xarelto |
| Avinger INC. | $55.92 | 2023 | Pantheris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.98 | 2022-2025 | Jardiance |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $43.99 | 2021-2023 | Uptravi, Opsumit |
| Chiesi USA, INC. | $37.27 | 2022-2023 | Kengreal |
| Bayer Healthcare Pharmaceuticals INC. | $27.85 | 2023-2024 | |
| Angiodynamics, INC. | $26.43 | 2025 | Auryon Laser System 100-120 Vac |
| Alnylam Pharmaceuticals INC. | $24.46 | 2023 | Onpattro |
| Esperion Therapeutics, INC. | $19.07 | 2023 | Nexletol |
| Sanofi-Aventis U.S. LLC | $17.11 | 2022 | |
| Eagle Pharmaceuticals, INC. | $16.59 | 2022 | |
| Shockwave Medical, INC | $15.39 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $14.73 | 2022 | |
| Scpharmaceuticals INC. | $13.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittnee Angle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.